Occudo Quantitative Strategies’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
+25,788
| New | +$231K | 0.03% | 520 |
|
|
2024
Q1 | – | Sell |
-27,022
| Closed | -$162K | – | 743 |
|
|
2023
Q4 | $162K | Buy |
+27,022
| New | +$162K | 0.02% | 673 |
|
|
2023
Q3 | – | Sell |
-19,110
| Closed | -$135K | – | 985 |
|
|
2023
Q2 | $135K | Buy |
+19,110
| New | +$135K | 0.01% | 900 |
|
|
2022
Q4 | – | Sell |
-61,459
| Closed | -$774K | – | 974 |
|
|
2022
Q3 | $774K | Buy |
+61,459
| New | +$774K | 0.06% | 512 |
|
|
2021
Q1 | – | Sell |
-87,019
| Closed | -$648K | – | 755 |
|
|
2020
Q4 | $648K | Buy |
+87,019
| New | +$648K | 0.2% | 155 |
|